跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PEMETREXED FOR INJECTION, USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PEMETREXED FOR INJECTION, USP
Authorized
STANDARD
PEMETREXED FOR INJECTION, USP
dr reddy's laboratories ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
d52fbad659c04aef
Company
dr reddy's laboratories ltd
Type
Standard
Approval Details
Approval Id
d52fbad659c04aef
Drug Approval Canada Name
PEMETREXED FOR INJECTION, USP
Product Name
PEMETREXED FOR INJECTION, USP
Status
Marketed
Status Date
2022-06-17
Original Market Date
2022-06-17
Din
02463091
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01BA04 PEMETREXED
Atc Name
l 01 ba 04
Aig Number
0150104001
Company Name
dr reddy's laboratories ltd
Company Address
Survey Nos. 42, 45, 46 & 54, Innovation Plaza, Bachupally, Medchal-Malkajgiri, Telangana, India, 500090
Active Ingredients
PEMETREXED (PEMETREXED DISODIUM)
500 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
d52fbad659c04aef
Type
Standard
Back to Health Canada Approvals